Purpose: To report the results of a study evaluating JetStream atherectomy for the treatment of in-stent restenosis (ISR).
Materials And Methods: The JetStream XC atherectomy device, a rotational cutter with aspiration capacity, was evaluated in a prospective, multicenter study (JET-ISR) of 60 patients (mean age 70.2±10.8 years; 40 men) with femoropopliteal ISR ( identifier NCT02730234). Lesion length was 19.9±13.5 cm; 33 (55%) were chronic total occlusions and 26 (45%) were TransAtlantic Inter-Society Consensus class D. No drug-bearing device was allowed, and stenting was performed only for bailout. Lesion characteristics and stent integrity were evaluated by an independent core laboratory. The primary endpoint was target lesion revascularization (TLR) at 6 months with bailout stenting considered as TLR. Secondary endpoints included TLR (without bailout stenting) and clinical patency (no restenosis or TLR) at 1 year. The Kaplan-Meier method was employed to evaluate time-to-event endpoints; estimates are given with 95% confidence interval (CI).
Results: Bailout stenting was required in 6 of 60 limbs (10%). There were no stent fractures or deformities after atherectomy + adjunctive angioplasty reported by the core laboratory. Kaplan-Meier estimates of freedom from TLR at 6 months and 1 year were 79.3% (95% CI 68.9% to 89.8%) and 60.7% (95% CI 47.8% to 73.6%), respectively. When bailout stenting at the index procedure was not considered a TLR event, freedom from TLR estimates at 6 months and 1 year were 89.3% (95% CI 81.2% to 97.4%) and 66.8% (95% CI 54.3% to 74.2%), respectively. Clinical patency rates at 6 months and 1 year were 77.5% (31/40) and 51.7% (15/29), respectively.
Conclusion: JetStream atherectomy using the XC device and no drug-eluting devices is feasible, with good clinical patency and 1-year freedom from TLR.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/1526602820951916 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A case of pseudoaneurysm after endovascular therapy with atherectomy and paclitaxel-coated balloon for superficial femoral artery lesion.
J Cardiol Cases
July 2024
Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan.
Article Synopsis
- An 83-year-old woman with leg pain underwent endovascular therapy (EVT) for severe stenosis in the right superficial femoral artery (SFA) using the Jetstream™ atherectomy system and a paclitaxel-coated balloon (PCB).
- Although the initial procedure showed lumen improvement, her symptoms returned 9 months later due to the development of a pseudoaneurysm and severe stenosis.
- This case highlights the risk of pseudoaneurysm as a complication of EVT with the Jetstream™ system, despite its benefits in treating calcified arterial lesions.
Management of Pseudoaneurysm as a Delayed Complication after Using Rotational Atherectomy in Popliteal Artery Atherosclerosis: A Case Report.
Vasc Specialist Int
June 2024
Division of Vascular and Endovascular Surgery, Department of Surgery, Pusan National University Yangsan Hospital, School of Medicine, Pusan National University, Yangsan, Korea.
Although intravascular atherectomy is widely used for debulking calcified atheromas in peripheral arterial disease, it is associated with complications. Delayed rupture with pseudoaneurysm formation is rare. We report the case of a 73-year-old man who developed a 24 mm×20 mm×27 mm popliteal artery (PA) pseudoaneurysm after rotational atherectomy.
View Article and Find Full Text PDFSex-Specific Analysis of Mid-Term Outcomes of Atherectomy-Assisted Endovascular Treatment in Severe Peripheral Arterial Disease.
J Clin Med
May 2024
Rhein Main Vascular Center, Department of Vascular and Endovascular Surgery, Asklepios Clinics Langen, Paulinen Wiesbaden, 63225 Langen, Germany.
Endovascular treatment of lower-extremity peripheral disease (PAD) is associated with higher complication rates and suboptimal outcomes in women. Atherectomy has shown favourable outcomes in calcified lesions, minimising the incidence of stent placement caused by recoil or flow-limiting dissection. To date, there are no published mid-term outcomes evaluating the performance of atherectomy differentiated by sex.
View Article and Find Full Text PDFA case of in-stent restenosis due to mechanical compression caused by the protrusion of calcified nodules successfully treated with a Jetstream™ atherectomy system followed by a drug-coated balloon angioplasty.
Cardiovasc Interv Ther
July 2024
Cardiovascular Division, Osaka Police Hospital, 2-6-40 Karasugatsuji, Tennoji Ward, Osaka, 543-0042, Japan.
Midterm outcomes of rotational atherectomy-assisted endovascular treatment of severe peripheral arterial disease.
J Vasc Surg
April 2024
Department of Vascular and Endovascular Surgery, Asklepios Clinic Langen, Langen, Germany.
Objective: We evaluated the midterm results of atherectomy-assisted angioplasty for the treatment of femoropopliteal lesions and the identification of possible subgroups of patients with superior outcomes.
Methods: We conducted a single-center, physician-initiated, nonindustry-sponsored retrospective analysis of patients with Rutherford category ranging from II to V and de novo occlusive or stenotic lesions of the superficial femoral (SFA) and/or popliteal arteries treated with atherectomy-assisted angioplasty (Jetstream rotational atherectomy + drug-eluting ballooning). In cases of subintimal recanalization or patients without an SFA stamp, with previous ipsilateral bypass surgery, systemic coagulopathy, end-stage renal disease requiring hemodialysis, life expectancy of <12 months, and intolerance to aspirin, clopidogrel, and/or heparin were excluded.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!